AML &amp; ALL are hematological cancers $AIKI is working on KPC-34. Cytarabine (Ara-C) has been a major drug for acute myeloid leukemia (AML) treatment for more than three decades. But KPC34 has shown superior results when tested against Cytarabine Owned by Pfizer $PFE https://t.co/HnPSP8lwZl